secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001040130-25-000034
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express prelim Q4 sales $51-53M vs $66.5M; net loss widens to $10M; delays 10-K
--------------------------------------------------------------------------------

- Q4 net sales estimated $51.1-53.1M (down ~21% YoY); net loss $9.9-10.4M vs $5.0M prior year.
- FY2025 net sales $231.6-233.6M (down ~17% YoY); FY net loss $4.5-5.0M vs $7.5M prior year.
- FY net loss includes $8.7M non-cash benefit from executive departure and $6.4M deferred tax asset valuation allowance.
- Cash position $54.7M with no debt as of March 31, 2025.
- Company filed Form 12b-25; expects to file annual 10-K by July 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/0001040130-25-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/pets-20250616.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer